Effects of chronic exposure to hydroxychloroquine or chloroquine on inner retinal structures

Eye

Volumn 24, Issue 2, 2010, Pages 340-346

  Pasadhika, S ^a,b   Fishman, G A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Hydroxychloroquine; Nerve fibre layer; OCT; Retinal thinning

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DRUG EXPOSURE; DRUG MONITORING; DRUG WITHDRAWAL; EYE FUNDUS; EYE TOXICITY; FEMALE; HUMAN; IMAGE ANALYSIS; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY FAILURE; LONG TERM EXPOSURE; MACULA INNER RETINA THICKNESS; MACULA INNER RETINA THINNING; MACULA OUTER RETINA THICKNESS; MACULA OUTER RETINA THINNING; OPTICAL COHERENCE TOMOGRAPHY; PERIPAPILLARY RETINA NERVE FIBER LAYER THINNING; PERIPAPILLARY RETINA NERVE THICKNESS; RACE DIFFERENCE; RETINA DISEASE; RETINA MACULA LUTEA; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THICKNESS; TREATMENT DURATION; VISUAL SYSTEM PARAMETERS;

EID: 77049115207     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.65     Document Type: Article

References (15)

1. Bernstein HN. Chloroquine ocular toxicity. Surv Ophthalmol 1967; 12: 415-447.
2. Levy GD, Munz SJ, Paschal J, Cohen HB, Pince KJ, Peterson T. Incidence of hydroxychloroquine retinopathy in 1207 patients in a large multicenter outpatient practice. Arthritis Rheum 1997; 40: 1482-1486.
3. Marmor MF, Carr RE, Easterbrook M, Farjo AA, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology. Ophthalmology 2002; 109: 1377-1382.
4. Lowes M. Peripheral visual field restriction in chloroquine retinopathy. Report of a case. Acta Ophthalmol (Copenh) 1976; 54: 819-826.
5. Butler I. Retinopathy Following the use of chloroquine and allied substances. Ophthalmologica 1965; 149: 204-208.
6. Duncker G, Schmiederer M, Bredehorn T. Chloroquineinduced lipidosis in the rat retina: a functional and morphological study. Ophthalmologica 1995; 209: 79-83.
7. Duncker G, Bredehorn T. Chloroquine-induced lipidosis in the rat retina: functional and morphological changes after withdrawal of the drug. Graefes Arch Clin Exp Ophthalmol 1996; 234: 378-381.
8. Rosenthal AR, Kolb H, Bergsma D, Huxsoll D, Hopkins JL. Chloroquine retinopathy in the rhesus monkey. Invest Ophthalmol Vis Sci 1978; 17: 1158-1175.
9. Gonasun LM, Potts AM. In vitro inhibition of protein synthesis in the retinal pigment epithelium by chloroquine. Invest Ophthalmol 1974; 13: 107-115.
10. Ivanina TA, Sakina NL, Lebedeva MN, Borovjagin VL. A study of the mechanisms of chloroquine retinopathy. II. Chloroquine effect on protein synthesis of retina. Ophthalmic Res 1989; 21: 272-277.
11. Ivanina TA, Sakina NL, Lebedeva MN, Borovyagin VL. A study of the mechanisms of chloroquine retinopathy. I. Chloroquine effect on lipid peroxidation of retina. Ophthalmic Res 1989; 21: 216-220.
12. Hallberg A, Naeser P, Andersson A. Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse. Acta Ophthalmol (Copenh) 1990; 68: 125-130.
13. Vajaranant TS, Seiple W, Szlyk JP, Fishman GA. Detection using the multifocal electroretinogram of mosaic retinal dysfunction in carriers of X-linked retinitis pigmentosa. Ophthalmology 2002; 109: 560-568.
14. Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 2003; 110: 1321-1326.
15. Bonanomi MT, Dantas NC, Medeiros FA. Retinal nerve fibre layer thickness measurements in patients using chloroquine. Clin Experiment Ophthalmol 2006; 34: 130-136.